Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of Migraine
This study has been completed.
Study NCT00210496 Information provided by Janssen-Ortho LLC
First Received: September 13, 2005 Last Updated: July 17, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Migraine
Common Migraine
Classic Migraine
Additional conditions recognized in this trial
Migraine Disorders
Migraine with Aura
Migraine without Aura
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Headache Disorders
Headache Disorders, Primary
Nervous System Diseases
Interventions listed in this trial
topiramate; almotriptan malate
Additional drug interventions recognized in this trial
Almotriptan
Topiramate
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neuroprotective Agents
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Serotonin Agents
Serotonin Agonists
Therapeutic Uses
Sponsors listed in this trial
Janssen-Ortho LLC
Ortho-McNeil Neurologics, Inc.
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
Back to top of Main Content
